Effects of Chinese herbal medicine fuzhisan on aged rats

Experimental Gerontology

Volumn 43, Issue 9, 2008, Pages 853-858

  Li, Xu Ling ^a   Wang, De Sheng ^a   Zhao, Bao Quan ^b   Li, Qian ^b   Qu, Heng Yan ^b   Zhang, Ting ^b   Zhou, Jian Ping ^b   Sun, Man Ji ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Acetylcholine (ACh); Aging; Cerebral metabolism; Choline O acetyltrasferase (ChAT); Cognitive ability; Fuzhisan (FZS)

Indexed keywords

ACETYLCHOLINE; ACORUS TALARINOWI EXTRACT; CHOLINE ACETYLTRANSFERASE; FLUORODEOXYGLUCOSE F 18; FUZHISAN EXTRACT; GINSENG EXTRACT; GLYCYRRHIZA URALENSIS FISCH EXTRACT; PLANT EXTRACT; SCUTELLARIA BAICALENSIS EXTRACT;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHINESE MEDICINE; CHOLINERGIC SYSTEM; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; ENERGY RESOURCE; GLUCOSE METABOLISM; HIPPOCAMPUS; LATENT PERIOD; MALE; MAZE TEST; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ACETYLCHOLINE; AGING; ANIMALS; BRAIN; CHOLINE O-ACETYLTRANSFERASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; GLUCOSE; HIPPOCAMPUS; MALE; MAZE LEARNING; PHYTOTHERAPY; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, WISTAR; REACTION TIME;

MUS; RATTUS;

EID: 49749152418     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2008.05.018     Document Type: Article

References (35)

1. Idbaih A., Burlet A., Adle-Biassette H., Boisgard R., Coulon C., Paris S., Marie Y., Donadieu J., Hoang-Xuan K., and Ribeiro M.-J. Altered cerebral glucose metabolism in an animal model of diabetes insipidus: A micro-PET study. Brain Res. 1158 (2007) 164-168
2. Akihiro Noda., Hiroyuki Ohba., Takeharu Kakiuchi., Masami Futatsubashi., Hideo Tsukada., and Shintaro Nishimura. Age-related changes in cerebral blood flow and glucose metabolism in conscious rhesus monkeys. Brain Research 936 (2002) 76-81
3. Ayla Ozturk., Steven T., DeKosky M., and Ilyas Kamboh. Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease. Neurobiology of Aging 27 (2006) 1440-1444
4. Brookmeyer R., Gray S., and Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am. J. Public Health 88 (1998) 1337-1342
5. Chao L.P. Spectrophotometric determination of choline acetyltransferase in the presence of dithiothreitol. Anal. Biochem. 85 (1978) 20-24
6. Chao L.P., and Wolfgram F. Spectrophotometric assay for choline acetyltransferase. Anal. Biochem. 46 (1972) 114-118
7. Colom L.V. Septal networks: relevance to theta rhythm, epilepsy and Alzheimer's disease. J. Neurochem. 96 (2006) 609-623
8. Den Heijer T., Geerlings M.I., Hoebeek F.E., Hofman A., Koudstaal P.J., and Breteler M.M. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people. Arch. Gen. Psychiatry 63 (2006) 57-62
9. Erickson C.A., and Barnes C.A. The neurobiology of memory changes in normal aging. Exp. Gerontol. 38 (2003) 61-69
10. Ertekin-Taner N., Graff-Radford N., Younkin LH., Eckman C., Baker M., and Adamson J. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science 290 (2000) 2303-2304
11. Fu Ailing., Huang Shijie., and Sun Manji. Complementary remedy of age-related learning and memory deficits via exogenous choline acetyltransferase. Biochemical and Biophysical Research Communications 336 (2005) 268-273
12. Fu AiLing., Li Qian., Dong ZhaoHui., Huang ShiJie., Wang YuXia., and Sun ManJi. Alternative therapy of Alzheimer disease via supplementation with choline acetyltransferase. Neurosci. Lett. 368 (2004) 258-262
13. Gang Baozhi., Wang Desheng., and Wang Chunli. The efficacy of fuzhisan in patients with Alzheimer's disease. J. Apoplexy and Nervous Disease 22 (2005) 535-537
14. Herholz K., Salmon E., Perani D., Baron J.C., Holthoff V., Frölich L., Schönknecht P., Ito K., Mielke R., Kalbe E., Zündorf G., Delbeuck X., Pelati O., Anchisi D., Fazio F., Kerrouche N., Desgranges B., Eustache F., Beuthien-Baumann B., Menzel C., Schröder J., Kato T., Arahata Y., Henze M., and Heiss W.D. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. NeuroImage 17 (2002) 302-316
15. Holliday R. The urgency of research on ageing. Bioessays 18 (1996) 89-90
16. Jeffrey N Keller. Age-related neuropathology, cognitive decline, and Alzheimer's disease. Ageing Research Reviews 5 (2006) 1-13
17. Jones W.F., Digby W.M., Luk W.K., Casey M.E., and Byars L.G. Optimizing rod window width in positron emission tomography. IEEE Trans.Med Imag 14 (1995) 266-270
18. Kou Junping., Zhu Danni., and Yan Yongqing. Neuroprotective effects of the aqueous extract of the Chinese. Journal of Ethnopharmacology 97 (2005) 313-318
19. Li Xuling., Wang Desheng., Sun Manji., Zhao Baoquan., Tang Ying., Zhang Ting., Qu Hengyan., and Li Qian. Effect of Fuzhi San on Alzheimer's disease model mice. Chinese Pharmacological Bulletin 23 (2007) 421-424
20. Loessner A., Alavi A., Lewandrowski K.U., Mozley D., Souder E., and Gur R.E. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. J. Nucl. Med. 36 (1995) 1141-1149
21. Lowry O.H., Rosebrough A.L., and Randall F.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
22. Mielke R., Kessler J., Szelies B., Herholz K., Wienhard K., and Heiss W.D. Normal and pathological aging - findings of positron-emission-tomography. J. Neural Transm. 105 (1998) 821-837
23. Mungas D., Harvey D., Reed B.R., Jagust W.J., DeCarli C., Beckett L., Mack W.J., Kramer J.H., Weiner M.W., Schuff N., and Chui H.C. Longitudinal volumetric MRI change and rate of cognitive decline. Neurology 65 (2005) 565-571
24. Perry E.K., Tomlinson B.E., and Blessed G. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med 2 (1978) 1457-1459
25. Petersen R.C., Stevens J.C., Ganguli M., Tangalos E.G., Cummings J.L., and DeKosky S.T. Practice parameter: early detection of dementia: Mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56 (2001) 1133-1142
26. Shimoji K., Ravasi L., Schmidt K., Soto-Montenegro M.L., Esaki T., Seidel J., Jagoda E., Sokoloff L., Green M.V., and Eckelman W.C. Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18 F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling. J. Nucl. Med. 45 (2004) 665-672
27. Tang M.H., Kou J.P., Zhu D.N., and Yan Y.Q. Optimization of extracting technology on Danggui-shaoyao-san by orthogonal design and repeated test. China Journal of Chinese Materia Medica 25 (2000) 668-671
28. Vincent D., Segonzac G., and Vincent M.C. Colorimetric determination of acetylcholine by the Hestrin hydroxylamine reaction and its application in pharmacy. Ann. Pharm. Fr 16 (1958) 179-185
29. Vinutha B., Prashanth D., and Salma K. Screening of selected Indian medicinal plants for acetylcholinesterase inhibitory activity. Journal of Ethnopharmacology 109 (2007) 359-363
30. Wang Desheng., Xu Xiaoyun., and Wen Shiyong. The efficacy of FZS Nimodipine, GM1 in Alzheimer's disease. Information on Traditional Chinese Medicine 6 (1998) 49-51
31. Wen S.rong., Wang D.sheng., and Zhang J.yan. The effect of FZS on the celluler function of SH-SY5Y. Journal of harbin medical university 37 (2003) 383-388
32. Wen S.rong., Wang D.sheng., and Zhang J.yan. Effect of fuzhisan on the area of neurosome and the length of axon. Journal of Chinese clinical rehabilitation 9 (2005) 241-243
33. Wen S.rong., Wang D.sheng., and Zhang J.yan. Effect and mechanism of fuzhisan on toxic reaction of amyloid beta 25-35 to neural cells. Chinese Journal of Clinical Rehabilitation 9 (2005) 248-249
34. Whitehouse P.J., Price D.L., Clark A.W., Coyle J.T., and DeLong M.R. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10 (1981) 122-126
35. Zakzanis K.K., Graham S.J., and Campbell Z. A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: a neuroimaging profile. Neuropsychol. Rev. 13 (2003) 1-18